Summary: A gas Chromatographie procedure for the simultaneous determination of carbamazepine, phenobarbital and phenytoin using SP 2510 DA as stationary phase is presented. The antiepileptic drugs are determined simultaneously without derivatisation under isothermal conditions by a flame ionisation detector. The gas Chromatographie procedure can be easily mechanized. The coefficient of variation for the precision from day to day is 8.9% for carbamazepine, 7.0% for phenobarbital and 4.3% for phenytoin as calculated from single determinations. The deviations from the target value of spiked pool sera range from 4.3 to 9.5%. The gas Chromatographie results of this method and of determinations by Dexsil 300 for primidone and SP 1000 for ethosuximide are compared with the corresponding enzyme immunoassays (EMIT). The precision of the gas Chromatographie methods is somewhat better than EMIT. When patients' sera are analysed by both procedures the results show no clinically relevant differences. It can be concluded that the different methods are interchangeable and may be selected according to practical necessities.
Introduction
In general gas-Chromatographie procedures for the measurement of antiepileptic chrugs are -though reliableless practicable than EMIT. In order to improve practicability we used the newly available stationary phase SP 2510 DA (1, 2) that allows the simultaneous determination of antiepileptic drugs without derivatisation under isothermal conditions -important prerequisites for a mechanization of gas chromatography. As EMIT analyses are in widespread use we were interested in the comparison of results obtained by these two procedures, to see if they are interchangeable (3) (4) (5) (6) (7) (8) (9) (10) . Identical values would mean that the methods could be selected according to practical necessities, different values that at least one method is less reliable. In order to enable a 0340-076X/81/0019-0249S02.00final conclusion on the diagnostic strategy using EMIT we decided to incorporate the comparison of results by gas chromatography and EMIT for ethosuximide and primidone.
Procedure
The determinations were performed as previously described (5) using an Eppendorf analyzer 5010 (Eppendorf, D-2000 Hamburg). The results were calculated by on-line data processing using an empirical spline interpolation (13) . The substances are dissolved in ethyl acetate/acetic acid (100 ml + 1 ml): 100 mg/1. The solutions are stable for at least 3 months at 4 °C. The other drugs used for interference studies were obtained as gifts from the pharmaceutical manufacturers. The other chemicals were obtained from Merck, D-6100 Darmstadt. The organic solvents were distilled before use.
Material and Methods

Gas chromatography
Materials
Stationary phases: 3% SP 2250 DA on Supelcoport 100/120 mesh 3% Dexsil 300 on Supelcoport 100/120 mesh 2% SP 2510 DA on Supelcoport 100/120 mesh 1% SP 1000 on Supelcoport 100/120 mesh were purchased from Supelco, Belief onto (USA). Gas chromatography was performed using a Varian model 1440 (Varian, D-6100 Darmstadt) equipped with a flame ionisation detector.
Procedure
The determinations of the antiepileptics using SP 2250 DA, Dexsil-300 and SP-1000 were performed as described (11, 12) . In the case of SP 2510 DA the samples were prepared in the same manner as cited (11) , but before extraction the internal standard 5-(4'-methylphenyi-5-phenylhydantoin) (10 Mg) was added. Gas Chromatographie conditions: Oven 240 °C, inlet 265 °C, detector 265 °C; siliconised glass column (length: 0.90 m, internal diameter: 2 mm). Carrier gas (N2) flow rate: 40 ml/min, hydrogen 30 ml/min, air 300 ml/min.
Enzyme immunoassay (EMIT) Materials
Reagents for the enzyme immunoassay were obtained from Syva, Palo Alto (USA) (distributed in W. Germany by E. Merck, D-6100 Darmstadt). Specimen Serum samples were obtained from patients under therapy with antiepileptics at our hospital. Control sera: AED Antiepileptic drug control (Syva, Palo Alto, USA, distributed in W. Germany: Merck, D-6100 Darmstadt) Biotrol-therapeutique (Laboratoires Biotrol, Paris, France) Ortho Anticonvulsant Control Serum (Ortho Diagnostics, Raritan (USA)).
Statistics
The results obtained by gas chromatography and EMIT were compared by principal component analysis (14, 15) taking into account the imprecision of both methods. The correlation coefficient was calculated from the linear regression analysis, standard error as an estimate of random error according to L c. (16) . The significance of the difference between the means was determined by the sign test (a -5%) (17) .
Results and Discussion
/. Determination of carbamazepine, phenobarbital and phenytoin using SP2510 DA Precision Precision in the series: 2 ml of a drug-free serum i$ spiked with the antiepileptics to obtain concentrations in the therapeutic range. 1 ml and 1 ml are prepared separately and analysed by gas chrpmatography. The standard deviation is calculated according to I.e. (18) . The coefficients of variation (n = 10): Carbamazepir;e: 3.3%, phenobarbital: 1.4%, phenytoin: L9%. Precision from day to day: Spiked pool serum and commercially available control sera were measured on 10 days. The coefficients of variation based on single determinations vary between 4.3 and 10.9% (tab. 1).
Accuracy and specificity
The deviation from the target values during these ten days was between -8.5 and + 9.5% (tab. 1). Interfering compounds from the serum matrix were not observed, apart from cholesterol, which inhibits the precise measurement of primidone. Typical gas chromatogran\s are given in figure 1 and 2.
A possible interference in the determination by other drugs was evaluated as follows: The compound, or, if not available, a tablet, was dissolved in 10 ml ethyl acetate/acetic acid (100 ml + 1 ml) at an amount of at least 1 g/1 presuming sufficient solubility. 2 were ir> jected into the gas Chromatograph. In this way solubility and Chromatographie behaviour of the drugs in relation to the antiepileptics and the internal standard are evaluated simultaneously. The exact concentration of the Among the numerous substances tested only codeine in lethal concentrations could interfere with the determination of phenobarbital. In the future other drugs will be included in the evaluation, as well as their metabolites that are not easily available, and on the other-hand not very likely to interfere because of their usually high polarity. But already -from the substances thus far evaluated -one may conclude that the method is highly specific, though the assessment of specificity must remain by its nature open-ended.
Detectability
The detectability was estimated by calculation of the precision of the method at low concentrations (tab. 2) (11).
//. Comparison of the gas Chromatographie procedures and the enzyme immunoassay
Carbamazepine
Criteria of reliability
The precision of the carbamazepine determination is satisfactory for all methods, best for GC-Dexsil 300 l )\ Abbreviations: GC-SP 1000: Gas Chromatographie procedure using SP 1000 for the determination of ethosuximide (and valproate). GC-SP 2250 DA: Gas Chromatographie procedure using SP 2250 DA for the determination of phenobarbital and phenytoin. GODexsil 300: Gas chromato* graphic procedure using Dexsil-300 for the determination of carbamazepine and primidone. GC-SP 2510 DA: Gas Chromatographie procedure using SP 2510 DA for the determination of carbamazepine, phenobarbital and primidone without correction by the internal standard. GC-SP 2510 DA i.st: Gas Chromatographie procedure using SP 2510 DA for the determination of carbamazepine, phenobarbital and primidone with correction by the internal standard. In brackets: number of determinations * according to the manufacturer bearing in mind that the EMIT assays are always based on duplicates. The deviation from the target value is small (tab. 1). The interference by severe hemolysis is common to all EMIT assays (17) and not to the gas Chromatographie procedure. But as hemolysis has no influence on the EMIT procedure presented (5) up to a hemoglobin concentration of at least 2 g/1, it is of minor importance in routine use. The carbamazepine assay (EMIT) shows a small cross-reactivity with carbamazepine-10, 11-epoxide: 64 ìéçïÀ/À of this metabolite exert a change of absorbance equivalent to 11 ìéçïÀ/À carbamazepine. As furthermore the metabolite normally represents only a small portion of carbamazepine, it does not prevent an accurate measurement. Following the original EMIT procedure, carbamazepine concentrations down to 4.2 ìðéïÀ/À can be measured wjtii a precision equal to that obtained with the g&s Chromatographie procedures. Below this concentration the imprecision of both methods rapidly increases (tab. 2). In external quality control the values of the gas Chromatographie procedure GC-SP 2510 DA and of the EMIT are compared to the mean of all participants using the enzyme immunoassay (tab. 3). The data obtained by the GC-SP 2510 DA are more closely related to the mean of all participants using EMIT than our EMIT procedure itself. We think that this discrepancy is due to the greater imprecision of EMIT. On the other hand one may appreciate this as evidence that each method based on Tab. 3. Carbamazepine.
External quality control of the gas Chromatographie (SP 2510 DA) and the EMIT procedure.
Number of participants n (1) related to determinations by EMIT another principle possesses good accuracy and that the results are well comparable.
Patients' sera Serum samples of patients treated with carbamazepine were analysed by GC-SP 2510 DA, GC-SP 2510 DA i.st. and EMIT (fig. 3) . The use of the internal standard (5-(4'-methylphenyl)-5-phenylhydantoin) did not markedly improve the precision of the determination: The standard errors of estimation do not differ by more than 0.10 ìéçïÀ/l (3.42 to 3.32). GC-SP 2510 DA fits best to EMIT with no proportional error and a small intercept. Apparently both methods, EMIT and gas chromatography are reliable procedures for the measurement of carbamazepine.
Ethosuximide
Criteria of reliability
The precision of the ethosuximide determination by EMIT is better than expected (19) though worse than by GC-SP 1000 (tab. 1). The results differ only to a small extent from the target value. The cross-reactivity of glutethimide at (toxic) concentrations exceeding 100 mg/1 and of N-desmethylmethsuxirriide (19) in the EMIT assay was not observed with a gas Chromatographie procedure. From the similar imprecision at small concentrations it can be judged that both methods possess similar detectability far below the therapeutic range, if the EMIT results are calculated -as in the whole study -by the empirical spline interpolation (13) (tab. 2).
In external quality control (tab. 4) our results ate always within ± one standard deviation from the mean of the corresponding gas Chromatographie data, with the GC-SP 1000 data closer to the mean than the EMIT values.
The standardised principal component analysis of patients'sera analysed by GC-SP 1000 and EMIT ( fig. 4 ) reveals a distinct proportional error that is reflected in the significant differences of the mean values. The con- (2) 20.7 (2) 27.4 (2) 24.3 (2) 19.6 (2) Own deviation from y in % stant error is small as compared to the therapeutic range. The same is true for the standard error as a measure of random error. Ori the whole the differences of the values in the therapeutic range obtained by the two methods would not change the clinical interpretation.
Phenobarbital
Criteria of reliability
The precision of the methods is acceptable (tab. 
Phenytoin
Criteria of reliability
According to the coefficients of variation the gas Chromatographie procedures are more precise than EMIT 300.0 -Tab. 5. Phenobarbital.
External quality control of the gas Chromatographie (SP 2510 DA) and the EMIT procedure. The difference between the means is significant as calculated by the sign test (a = 5%) (17) EMIT seems to be more sensitive (tab. 2), if the empirical spline interpolation is used for calculation. The reason may be the flat peaks of phenytoin eluted as the last drug.
In external quality control (tab. 6) the results of the gas Chromatographie and the EMIT procedure are compared to the mean of enzyme immunoassay s. Because of their better precision the gas Chromatographie data are more closely related to the mean than the EMIT values, both with a slightly negative bias.
Patients' sera
The agreement between GC-SP 2510 DA and EMIT for patients' sera is good, showing only a small proportional and a small constant error (fig. 6 ). The mean values do not differ significantly and random error is acceptable. The use of the internal standard for the calculation of the results slightly improved reliability.
Primidone
Criteria of reliability
Because of the interference of cholesterol on SP 2510 DA, primidone could only be measured using Dexsil 300 (11). The gas Chromatographie procedure seems to be less precise than EMIT with a small positive bias (tab. 1). Of the drugs so far tested none interfered with the gas Chromatographie determination (11) . EMIT shows crossreactivity with 2-phenyl-2-ethylmalondiamide only at extremely high concentrations (> 500 mg/1) (19) . Both methods allow precise determinations in the subtherapeutic range (tab. 2).
The comparison of results from patients'sera ( fig. 7 ) reveals a distinct proportional error, which leads to a significant difference of the mean values, but not to a different interpretation by the clinicians.
Tab. 6. Phenytoin.
Number of participants (1) related to determinations by EMIT mechanized instruments are available that run the analyses unattended by the technicians.
In contrast to EMIT the reagents in gas chromatography are stable and easily available from many manufacturers. The apparatus used for EMIT is very often already at hand in the laboratory and can be used for other routine work, because of the short time necessary in photometry.
A gas Chromatograph will not be available in many laboratories for clinical chemistry. The time for a determination is rather long and a comparably small workload can be run on one instrument. On the other hand gas chromatography gives access to the determination of many other drugs for which an EMIT is not available.
The few results obtained in external quality control (tab. 7) may demonstrate at best an acceptable agreement of both methods with the mean of all EMIT assays.
Practicability
A major advantage of EMIT is its quick performance. 30 samples can be measured within 60 minutes if on line data processing is possible (5). The gas Chromatographie procedure requires 15 hours for the same number of analyses. But an equally mechanized gas Chromatograph may run this number of determinations automatically without personnel guidance thereby, sparing 12 hours of technician time, if a method is available that allows the determination of antiepileptic drugs without derivatisation under isothermal conditions. If, in addition, carbamazepine, phenobarbital and phenytoin are measured simultaneously, the number of analyses is reduced by 15% according to our statistics. If primidone can be included by use of an alkali flame ionisation detector, the reduction is 32%. If a single sample must be urgently processed, analysis by EMIT will take 15-40 rriin depending on one's instrumentation, whereas determination by the gas Chromatographie procedure will be accomplished within 2 hours.
The cost of a single analysis by EMIT using the Eppendorf 5010 is high and was calculated to be 53 US$ for phenytoin (0.30 US$ per minute effective working time of the technicians). It may be reduced, if an ACA (Automatic Clinical Analyzer, Du Pont de Nemours) is available (24 US$). A single determination by gas chromatography calculated under the same assumptions will cost 37 US $. A series of 20 samples analysed by EMIT will cost 7 US$ per sample using the Eppendorf 5010 and 14 US$ per sample using the gas Chromatographie procedure. Money can be spared in the case of EMIT, especially if the volume of the (expensive) reagents needed can be reduced, and in the case of gas chromatography, if
Conclusion
Among the stationary phases tested we prefer on the whole SP 2510 DA for the measurement of carbamazepine, phenobarbital and phenytoin, because of its reliability and practicability. It can be expected that as soon as we have an alkali flame ionisation detector primidone will be included. Hewitt et al. (2) separate interfering cholesterol during extraction, but the recovery of primidone is poor (69%). Godolphin et al.
(1) use a precolumn of SP 2250 DA for the same purpose, but this stationary phase is not well suited for the gas chromatography of carbamazepine and primidone. The use of the internal standard did not markedly improve the results. Obviously there is not yet an internal standard equally suited for all compounds.
The reliability of EMIT is acceptable, though on the whole somewhat lower than that of the gas Chromatographie procedures. Interferences by drugs cannot easily be detected. But the experimental data and experience from routine use show that inaccuracy due to unspecificity is rare in the EMIT assay for antiepileptic drugs.
The results of GC-SP 2510 DA are generally best comparable to those obtained by EMIT with the exception of phenobarbital that behaves better on GC-SP 2250 DA.
Although small, but significant differences were found between gas chromatography and EMIT in the determination of ethosuximide, phenobarbital and primidone, indicating an inaccuracy of one or both methods, the results are sufficiently similar for the methods to be interchangeable for their intended use in therapeutic drug monitoring. As far as practicability is concerned it may be advantageous that the reagents for gas chromatography are stable, cheap and freely available from many manufacturers. Because of its flexibility gas chromatography may be easily adapted to the measurement of many drugs of perhaps current interest, whereas determinations by EMIT will include always, only a rather limited number of substances and the development of new tests is time-consuming. 
